The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

For all the different subpopulations, having a CAC score > 100 strongly predicted risk of CV death (P < 0.007). Yet the ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

The results show dose-dependent LDL-lowering and, in contrast to what was seen previously with VERVE-101, no safety issues.

This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.

Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating ...

The lack of effect on QoL and oxygen consumption help cement the idea that the disease isn’t the same as obstructive HCM.

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

April 18, 2025 | Juan Granada, MD, and Brian Lindman, MD, share insights on tools and data that can be used to ahieve earlier diagnosis and intervention in valvular heart disease. Receive the the ...